Dallah Healthcare Company

SASE:4004 株式レポート

時価総額：ر.س15.2b

Dallah Healthcare マネジメント

マネジメント 基準チェック /14

Dallah Healthcareの CEO はAhmad bin Babaeerで、 Apr2021年に任命され、 の在任期間は 3.83年です。 は、会社の株式の0.002%を直接所有しており、その価値はSAR 297.76K 。経営陣と取締役会の平均在任期間はそれぞれ2.6年と2.3年です。

主要情報

Ahmad bin Babaeer

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間3.8yrs
CEOの所有権0.002%
経営陣の平均在職期間2.6yrs
取締役会の平均在任期間2.3yrs

経営陣の近況

Recent updates

Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

Jan 08
Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

With EPS Growth And More, Dallah Healthcare (TADAWUL:4004) Makes An Interesting Case

Dec 21
With EPS Growth And More, Dallah Healthcare (TADAWUL:4004) Makes An Interesting Case

Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio

Oct 31
Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio

The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising

Oct 07
The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising

Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?

Sep 19
Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?

Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 14
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)

Jul 18
The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)

Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

May 30
Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Apr 16
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Mar 18
What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Feb 25
Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Oct 30
Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Jul 26
Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Apr 17
Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Feb 06
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

Dec 05
Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Nov 01
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Aug 28
Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Aug 12
Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Jul 28
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

May 26
Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

May 20
Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Apr 16
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Feb 03
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Jan 10
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Oct 19
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Jul 09
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Jun 16
Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

May 02
Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Mar 17
What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Mar 02
Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Feb 15
Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Feb 01
Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 05
Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Dec 22
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Nov 20
Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

CEO（最高経営責任者

Ahmad bin Babaeer (66 yo)

3.8yrs

在職期間

ر.س8,000

報酬

Dr. Ahmad bin Saleh Babaeer serves as the Chief Executive Officer of Dallah Healthcare Company since April 2021. Dr. Babaeer served as General Manager of Dallah Hospital at Dallah Healthcare Holding Co. Dr...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Mohammed bin Al-Faqih
Executive Director & General Medical Supervisorno dataر.س2.89m4.84%
SAR 735.9m
Ahmad bin Babaeer
Chief Executive Officer3.8yrsر.س8.00k0.0020%
SAR 297.8k
Ali Bin Saeed Al Qahtani
Chief Financial Officer3.1yrsデータなしデータなし
Abdulaziz Al-Wahaibi
Chief Operating Officerno dataデータなしデータなし
Salah Al-Fagih
Chief Medical Officer8.1yrsデータなしデータなし
Muteab Al Tukeas
C.S.O.1.9yrsデータなしデータなし
Omar Aljabari
Chief Commercial Officer2.1yrsデータなしデータなし
Ismail Abdullah
Chief Digitization Officerless than a yearデータなしデータなし

2.6yrs

平均在職期間

71yo

平均年齢

経験豊富な経営陣: 4004の経営陣は 経験豊富 であると考えられます ( 2.6年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Mohammed bin Al-Faqih
Executive Director & General Medical Supervisorno dataر.س2.89m4.84%
SAR 735.9m
Tarek Othman Bin Al-Kasabi
Chairman of the Board11.3yrsر.س2.23m4.84%
SAR 735.9m
Mohiuddin Bin Saleh Abdullah Kamel
Vice Chairman of the Board2.3yrsر.س329.60k0.0016%
SAR 238.5k
Fahad Bin Abdullah Al-Qassim
Directorno dataر.س413.33kデータなし
Amr Bin Mohamed Kamel
Directorno dataر.س321.00kデータなし
Abdullah Bin Turki Al-Sudairy
Independent Director4.1yrsر.س347.00kデータなし
Talal Al-Maiman
Director2.3yrsデータなしデータなし
Mohamed Hefni
Director2.3yrsデータなしデータなし
Khalid Al Solai
Director1.9yrsデータなしデータなし

2.3yrs

平均在職期間

60.5yo

平均年齢

経験豊富なボード: 4004の 取締役会 は 経験豊富 ではない ( 2.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2025/02/06 11:55
終値2025/02/06 00:00
収益2024/09/30
年間収益2023/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Dallah Healthcare Company 7 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。22

アナリスト機関
Ibrahim ElaiwatAljazira Capital Company
Jassim Al-JubranAljazira Capital Company
Rim Ben Salah GharbiAlphaMena